PDE7B Blocking Peptide for STJ502373 peptide (STJ504669)
SPECIFICATIONS
ImmunogenSynthetic cyclic peptide common to all PDE7B variants.
General Information
| Short Description | PDE7B Blocking Peptide for STJ502373 is synthetically produced from the sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20ยฐC for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic cyclic peptide common to all PDE7B variants. |
| Specificity | This blocking peptide is recommended for use in combination with PDE7B antibody, STJ502373 |
Additional Info
| Background | Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in the control of cAMP-mediated neural activity and cAMP metabolism in the brain. |
Information sourced from Uniprot.org